Warfarin and aortic valve calcification in hemodialysis patients

Journal of Nephrology

Volumn 20, Issue 4, 2007, Pages 417-422

  Holden, Rachel M ^a   Sanfilippo, Anthony S ^a   Hopman, Wilma M ^b   Zimmerman, Deborah ^c   Garland, Jocelyn S ^a   Morton, A Ross ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b KINGSTON GENERAL HOSPITAL   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Aortic valve; Calcification; Hemodialysis; Warfarin

Indexed keywords

CALCITRIOL; CALCIUM; PHOSPHATE BINDING AGENT; WARFARIN;

ADULT; AGED; AORTA VALVE DISEASE; ARTICLE; CALCIFICATION; CALCIUM INTAKE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EXPOSURE; ECHOCARDIOGRAPHY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; RETROSPECTIVE STUDY; RISK ASSESSMENT; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; AORTIC VALVE STENOSIS; CALCINOSIS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; WARFARIN;

EID: 36049043173     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Cowell SJ, Newby DE, Prescott RJ, Bloomfield P, Reid J, Northridge DB, Boon NA; Scottish Aortic Stenosis and Lipid Lowering Trial IoRSI. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005; 352: 2389-97. See Comment.
2. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999; 341: 142-7. See Comment.
3. Umana E, Ahmed W, Alpert MA. Valvular and perivaivular abnormalities in end-stage renal disease [review]. Am J Med Sci 2003; 325: 237-42.
4. Straumann E, Meyer B, Misteli M, Blumberg A, Jenzer HR. Aortic and mitral valve disease in patients with end stage renal failure on long-term haemodialysis. Br Heart J 1992; 67: 236-9.
5. Maher ER, Young G, Smyth-Walsh B, Pugh S, Curtis JR. Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet 1987; 2: 875-7.
6. Goodman WG, London G, Amann K, Block GA, Giachelli C, Hruska KA, Ketteler M, Levin A, Massy Z, McCarron DA, Raggi P, Shanahan CM, Yorioka N; Vascular Calcification Work Group. Vascular calcification in chronic kidney disease [review]. Am J Kidney Dis 2004; 43: 572-9.
7. Shearer MJ. Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification [review]. Curr Opin Clin Nutr Metab Care 2000; 3: 433-8.
8. Koos R, Mahnken AH, Muhlenbruch G, Brandenburg V, Pflueger B, Wildberger JE, Kuhl HP. Relation of oral anticoagulation to cardiac valvular and coronary calcium assessed by multislice spiral computed tomography. Am J Cardiol 2005; 96: 747-9.
9. Schurgers LJ, Aebert H, Vermeer C, Bultmann B, Janzen J. Oral anticoagulant treatment: friend or foe in cardiovascular disease? Blood 2004; 104: 3231-2.
10. Wang AY, Woo J, Wang M, Sea MM, Ip R, Li PK, Lui SF, Sanderson JE. Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 2001; 12: 1927-36.
11. Varma R, Aronow WS, McClung JA, Garrick R, Vistainer PF, Weiss MB, Belkin RN. Prevalence of valve calcium and association of valve calcium with coronary artery disease, atherosclerotic vascular disease, and all-cause mortality in 137 patients undergoing hemodialysis for chronic renal failure. Am J Cardiol 2005; 95: 742-3.
12. Moe SM, Reslerova M, Ketteler M, O'neill K, Duan D, Koczman J, Westenfeld R, Jahnen-Dechent W, Chen NX. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 2005; 67: 2295-304.
13. Price PA, Faus SA, Williamson MK. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 1998; 18: 1400-7.
14. Ketteler M, Wanner C, Metzger T, Bongartz P, Westenfeld R, Gladziwa U, Schurgers LJ, Vermeer C, Jahnen-Dechent W, Floege J. Deficiencies of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremia [review]. Kidney Int Suppl 2003; (84): S84-7.
15. Demer LL, Tintut Y, Parhami F. Novel mechanisms in accelerated vascular calcification in renal disease patients [review]. Curr Opin Nephrol Hypertens 2002; 11: 437-43. Erratum in Curr Opin Nephrol Hypertens 2003; 12: 221.
16. Davies MR, Hruska KA. Pathophysiological mechanisms of vascular calcification in end-stage renal disease [review]. Kidney Int 2001; 60: 472-9.
17. Gage BF, Birman-Deych E, Radford MJ, Nilasena DS, Binder EF. Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2. Arch Intern Med 2006; 166: 241-6.
18. Rosenhek R, Klaar U, Schemper M, Scholten C, Heger M, Gabriel H, Binder T, Maurer G, Baumgartner H. Mild and moderate aortic stenosis: natural history and risk stratification by echocardiography. Eur Heart J 2004; 25: 199-205. See Comment.
19. Traynor JP, Walbaum D, Woo YM, Teenan P Fox JG, Mactier RA. Low-dose warfarin fails to prolong survival of dual lumen venous dialysis catheters. Nephrol Dial Transplant 2001; 16: 645.
20. Crowther MA, Clase CM, Margetts PJ, Julian J, Lambert K, Sneath D, Nagai R, Wilson S, Ingram AJ. Low-intensity warfarin is ineffective for the prevention of PTFE graft failure in patients on hemodialysis: a randomized controlled trial. J Am Soc Nephrol 2002; 13: 2331-7.